A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Public ClinicalTrials.gov record NCT06717425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF-07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine (PF-07976016) to those of participants who take placebo (a lookalike substance that contains no active study medicine). The aim is to measure the body's response to the study medicine, including any changes in participants' body weight and how well they tolerate the study medicine.
Study identification
- NCT ID
- NCT06717425
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2024
- Primary completion
- Oct 22, 2025
- Completion
- Jan 11, 2026
- Last update posted
- Feb 5, 2026
2024 – 2026
United States locations
- U.S. sites
- 28
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Clinical & Translational Research Center | Aurora | Colorado | 80045 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Westside Center for Clinical Research | Jacksonville | Florida | 32205 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| St Johns Center for Clinical Research | Saint Augustine | Florida | 32086 | — |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City | Georgia | 30291 | — |
| East-West Medical Research Institute | Honolulu | Hawaii | 96814 | — |
| Cotton O'Neil Diabetes & Endocrinology | Topeka | Kansas | 66606 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| StudyMetrix Research | City of Saint Peters | Missouri | 63303 | — |
| Rochester Clinical Research, LLC | Rochester | New York | 14609 | — |
| Accellacare - Wilmington | Wilmington | North Carolina | 28401 | — |
| AMR Clinical | Norman | Oklahoma | 73069 | — |
| Cornerstone Nutrition and Diabetes | Norman | Oklahoma | 73069 | — |
| Capital Area Research, LLC | Camp Hill | Pennsylvania | 17011 | — |
| Elligo Clinical Research Center | Austin | Texas | 78704 | — |
| Texas Diabetes & Endocrinology, P.A. | Austin | Texas | 78749 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| Southwest Internal Medicine, PC | St. George | Utah | 84790 | — |
| Selma Medical Associates | Winchester | Virginia | 22601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06717425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06717425 live on ClinicalTrials.gov.